Open AccessThe Role ofPsychedelics in Managing Anxiety, Depression, and Flashbacks of Individuals withPost-Traumatic Stress Disorder
Author(s) -
Reace L. Hammel,
Berry J. Gulliver,
Shelby N. Sukich,
Sam Abraham
Publication year - 2022
Publication title -
international journal of science and research methodology
Language(s) - English
Resource type - Journals
ISSN - 2454-2008
DOI - 10.25166/ijsrm/2022.20.3.2
Subject(s) - psilocybin , psychiatry , anxiety , psychology , traumatic stress , clinical psychology , depression (economics) , novelty , hallucinogen , psychotherapist , social psychology , economics , macroeconomics
Background: The impact of psychedelic treatment on patients with posttraumatic stress disorder (PTSD) has become more intriguing to the psychiatric field. Because of the stigma surrounding illicit drug use, the scientific communities were unable to conduct thorough studies regarding the effects of psychedelics on the brain. These drugs could help many people with mental illnesses that have not found adequate success with typical treatments. In recent years, there have been studies conducted to examine the use of psychedelics for the treatment of psychiatric disorders such as PTSD. Purpose: The purpose of this review was to bring awareness to the effectiveness of long-forbidden psychedelic treatments such as psilocybin. Method: Using a review of scholarly articles, this paper examines the effects of psilocybin on anxiety, depression, and flashbacks in patients with PTSD. Findings: Findings indicate a therapeutic effect on patients with PTSD when using psilocybin. Conclusion: Based on these findings, the medical community should take steps toward novelty treatments for psychiatric diagnoses; however, further studies may be implicated. Stigma against this class of medications remains an issue.